TRIM21 and Behcet disease: In addition, TRIM21 was found to be upregulated in monocytes from BD patients and stimulated the NF-κB signaling pathway, leading to the production of monocyte-derived proinflammatory cytokines and the promotion of Th1/Th17-mediated inflammation [28].